Cite
Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study.
MLA
Ruscica, Massimiliano, et al. “Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study.” Cancers, vol. 16, no. 7, Apr. 2024, p. 1411. EBSCOhost, https://doi.org/10.3390/cancers16071411.
APA
Ruscica, M., Macchi, C., Gandini, S., Macis, D., Guerrieri-Gonzaga, A., Aristarco, V., Serrano, D., Lazzeroni, M., Rizzuto, A. S., Gaeta, A., Corsini, A., Gulisano, M., Johansson, H., & Bonanni, B. (2024). Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study. Cancers, 16(7), 1411. https://doi.org/10.3390/cancers16071411
Chicago
Ruscica, Massimiliano, Chiara Macchi, Sara Gandini, Debora Macis, Aliana Guerrieri-Gonzaga, Valentina Aristarco, Davide Serrano, et al. 2024. “Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer—Evidence from a 17-Year Follow-Up Study.” Cancers 16 (7): 1411. doi:10.3390/cancers16071411.